Visceral leishmaniasis
Top View
- Emphasis on Kala-Azar in South Asia 2
- Low Castes Have Poor Access to Visceral Leishmaniasis Treatment in Bihar, India
- The Post Kala-Azar Dermal Leishmaniasis (PKDL) Atlas a Manual for Health Workers WHO Library Cataloguing-In-Publication Data
- Epidemiology of Parasitic Infections in the West Bank and Gaza Strip, Palestine
- One Health Approach to Leishmaniases: Understanding the Disease Dynamics Through Diagnostic Tools
- Visceral Leishmaniasis Caused by Leishmania Donovani Zymodeme
- Noninvasive Biological Samples to Detect and Diagnose Infections Due to Trypanosomatidae Parasites: a Systematic Review and Meta-Analysis
- Cross-Reactivity Using Chimeric Trypanosoma Cruzi Antigens
- Research on Malaria and Leishmaniasis
- Human African Trypanosomiasis, Chagas Disease and Leishmaniases
- Zoonoses and Communicable Diseases Common to Man and Animals
- Prevention, Diagnosis and Treatment of Visceral Leishmaniasis (Kala-Azar) in Kenya
- Visceral Leishmaniasis: What Are the Needs for Diagnosis, Treatment and Control?
- Challenges in Modeling Complexity of Neglected Tropical Diseases
- Guidelines for Diagnosis, Treatment and Prevention of Visceral Leishmaniasis in Somalia
- 1 Antiparasitic December 2016 Miltefosine (Impavido, Paladin Therapeutics) Non-Formulary
- Congenital Transmission of Visceral Leishmaniasis (Kala Azar) from an Asymptomatic Mother to Her Child
- Leishmaniasis (Cutaneous and Visceral) Cutaneous Leishmaniasis (E.G., L